Intra-arterial therapy of melanoma with dimethyl triazeno imidazole carboxamide (NSC-45388).

Abstract

CancerVolume 28, Issue 5 p. 1161-1164 ArticleFree Access Intra-arterial therapy of melanoma with dimethyl triazeno imidazole carboxamide (NSC-45388) Edwin D. Savlov MD, Corresponding Author Edwin D. Savlov MD Division of Oncology and Department of Surgery, University of Rochester Medical Center Rochester, N. Y., and Lahey Clinic Foundation, Boston, Mass.University of Rochester Medical Center, Rochester, N.Y.===Search for more papers by this authorThomas C. Hall MD, Thomas C. Hall MD Division of Oncology and Department of Surgery, University of Rochester Medical Center Rochester, N. Y., and Lahey Clinic Foundation, Boston, Mass.Search for more papers by this authorRichard A. Oberfield MD, Richard A. Oberfield MD Division of Oncology and Department of Surgery, University of Rochester Medical Center Rochester, N. Y., and Lahey Clinic Foundation, Boston, Mass.Search for more papers by this author Edwin D. Savlov MD, Corresponding Author Edwin D. Savlov MD Division of Oncology and Department of Surgery, University of Rochester Medical Center Rochester, N. Y., and Lahey Clinic Foundation, Boston, Mass.University of Rochester Medical Center, Rochester, N.Y.===Search for more papers by this authorThomas C. Hall MD, Thomas C. Hall MD Division of Oncology and Department of Surgery, University of Rochester Medical Center Rochester, N. Y., and Lahey Clinic Foundation, Boston, Mass.Search for more papers by this authorRichard A. Oberfield MD, Richard A. Oberfield MD Division of Oncology and Department of Surgery, University of Rochester Medical Center Rochester, N. Y., and Lahey Clinic Foundation, Boston, Mass.Search for more papers by this author First published: 1971 https://doi.org/10.1002/1097-0142(1971)28:5<1161::AID-CNCR2820280512>3.0.CO;2-VCitations: 23AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Gottlieb, J. A., and Luce, J. K.: Chemotherapy of malignant melanoma with intra-arterial infusions of dimethyl triazeno imidazole carboxamide. Presented at the American Society of Clinical Oncology, April 7, 1971 (abstr.). 2 Livingston, R. B., and Carter, S. K.: Single agents in cancer chemotherapy. N. Y., Plenum Publishing Company, 1970; p. 373. 3 Luce, J. K., et al.: Clinical trials with the antitumor agent 5-(3,3-dimethyl-l-triazeno)-imidazole-4-car- boxamide. NSC No. 45388. Cancer Chemother. Rep. 54: 119, 1970. 4 Moertel, C. G., Reitemeier, R. J., Hahn, R. G., and Schutt, A. J.: Study of 5-(3,3-dim'ethyl-l-triazeno)- imidazok-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma. Cancer Chemother. Rep. 54: 471– 473, 1970. 5 Nathanson, L., Hall, T. C., Vawter, G. F., and Farber, S.: Melanoma as a medical problem. Arch. Intern. Med. 119: 479, 1967. 6 Nathanson, L. T., et al.: Clinical characteristics of prognosis and response to an irnidazole carboxamide in malignant melanoma. Submitted for publication: Ann. Intern. Med. 1971. 7 Savlov, E. D., and Hall, T. C.: Response of localized melanoma to intra-arterial dimethyl triazeno imidazole carboxamide. A case report. J. Sure:. Oncol. 2: 341– 347, 1970. 8 Sullivan, R. D.: Clinical cancer chemotherapy, including ambulatory infusion. Springfield, Ill., Charles C Thomas Publishers, 1970. 9 Wagner, D. E., Ramirez, G., Weis, J. A., and Hill, G., Jr.: Combination phase I-II study of imidazole carboxamide. NSC No. 45388. Presented at American Society of Clinical Oncology, April 7, 1971 (abstr.). Citing Literature Volume28, Issue51971Pages 1161-1164 ReferencesRelatedInformation